TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for F9
check button Gene summary
Basic gene informationGene symbolF9
Gene namecoagulation factor IX
SynonymsFIX|HEMB|P19|PTC|THPH8
CytomapUCSC genome browser: Xq27.1-q27.2
Type of geneprotein-coding
RefGenesNM_000133.3,
DescriptionChristmas factorF9 p22FIX F9factor 9factor IX F9plasma thromboplastic componentplasma thromboplastin component
Modification date20141219
dbXrefs MIM : 300746
HGNC : HGNC
Ensembl : ENSG00000101981
HPRD : 02385
Vega : OTTHUMG00000022536
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_F9
BioGPS: 2158
PathwayNCI Pathway Interaction Database: F9
KEGG: F9
REACTOME: F9
Pathway Commons: F9
ContextiHOP: F9
ligand binding site mutation search in PubMed: F9
UCL Cancer Institute: F9
Assigned class in TissGDB*B
Included tissue-specific gene expression resourcesHPA,TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Liver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)LIHC
Reference showing the relevant tissue of F9
Description by TissGene annotationsTissgsKTS
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for F9

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
LIHC10.4347620813.78654408-3.3517827.09E-096.43E-08


Top
TissGene-miRNA for F9

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for F9
TissGeneSNV for F9

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.R384*UCEC2
p.G442RSKCM2
p.R298QUCEC2
p.P197SSKCM2
p.D378NHNSC1
p.E231KSKCM1
p.M6IBLCA1
p.C134YLUAD1
p.E35KSKCM1
p.Q167*UCS1
p.E116KLUAD1
p.K109NOV1
p.L32FSKCM1
p.F55LCOAD1
p.E142DLGG1
p.P239HTHCA1
p.G106SHNSC1
p.G253RSKCM1
p.D131_spliceLUSC1
p.N452HKIRC1
p.V419LLUSC1
p.Q167XUCS1
p.R226LLUAD1
p.R43WSKCM1
p.G280_spliceGBM1
p.R75*UCEC1
p.F238LHNSC1
p.T264AUCEC1
p.V273IHNSC1
p.T381ICOAD1
p.N113SUCEC1
p.C69RBLCA1
p.R294*CESC1
p.I284FHNSC1
p.P12TLUAD1
p.R46KHNSC1
p.I336LCOAD1
p.A279TGBM1
p.G357VCOAD1
p.N213SLUAD1
p.G421RSKCM1
p.D410NSKCM1
p.E61QLUSC1
p.R162*SKCM1
p.G160RLUSC1
p.N48DUCEC1
p.K126NUCEC1
p.V257ICOAD1
p.A279TLGG1
p.M8TLUAD1
p.Q219KCESC1
p.Q370XSKCM1
p.D410ELUAD1
p.G402ALUAD1
p.Y391NBLCA1
p.A279TUCEC1
p.G254SLUAD1
p.Q370*SKCM1
p.D150GSTAD1
p.K387RSTAD1
p.R62ICOAD1
p.F123SREAD1
p.C145SLUSC1
p.E285DLUAD1
p.T264NLUAD1
p.F395LREAD1
p.G139SSKCM1
p.R298*GBM1
p.R162XSKCM1
p.E159DSTAD1
p.C128WGBM1
p.R384*LGG1
p.R298QHNSC1
p.M394LUCEC1
p.C108YTHYM1
p.E171KSKCM1
p.T386ISTAD1
p.D212NSKCM1
p.W261LSTAD1
p.Q143RLUAD1
p.S448YLUAD1
p.N343ILUAD1
p.G363RLUAD1
p.S184LSKCM1
p.R191STHCA1
p.P324LLGG1
p.L372IUCEC1
p.I7MHNSC1
p.S411RLUAD1
p.L376FSTAD1
p.P197LSKCM1
p.Y305HESCA1
p.P177LCESC1
p.P172LSKCM1
p.N295KLUSC1
p.A164VBRCA1
p.V181FUCEC1
p.V257IUCEC1


Top
TissGeneCNV for F9

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for F9

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for F9

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (tumor)F9, HNF4A, ONECUT1, AR, CEBPA, NR2F1, F2, LRP1, NR2F2, FLG, GGCX, SERPINC1, F8, F7 (normal)
bullet pointbullet point


Top
TissGeneProg for F9

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for F9
TissGeneDrug for F9

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status
DB13150Coagulation factor VII humanActivatorBiotechApproved


Top
TissGeneDisease for F9

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0008533Hemophilia B315BeFree,CLINVAR,CTD_human,GAD,LHGDN,MGD,UNIPROT
umls:C0019069Hemophilia A82BeFree,CTD_human,GAD
umls:C0549473Thyroid carcinoma77BeFree
umls:C0684275Hemophilia, NOS53BeFree
umls:C0238463Papillary thyroid carcinoma44BeFree
umls:C0005779Blood Coagulation Disorders42BeFree
umls:C0007115Malignant neoplasm of thyroid32BeFree
umls:C0007133Carcinoma, Papillary26BeFree
umls:C0206659Embryonal Carcinoma26BeFree
umls:C0596263Carcinogenesis22BeFree
umls:C0040136Thyroid Neoplasm13BeFree
umls:C0206682Follicular thyroid carcinoma12BeFree
umls:C0040137Thyroid Nodule10BeFree
umls:C0023493Adult T-Cell Lymphoma/Leukemia8BeFree
umls:C0205647Follicular adenoma8BeFree
umls:C0238461Anaplastic thyroid carcinoma8BeFree
umls:C0027627Neoplasm Metastasis7BeFree
umls:C0018021Goiter6BeFree
umls:C0398623Thrombophilia6BeFree,LHGDN
umls:C0686619Secondary malignant neoplasm of lymph node6BeFree
umls:C0016667Fragile X Syndrome5BeFree
umls:C0019087Hemorrhagic Disorders5BeFree
umls:C0019693HIV Infections5BeFree
umls:C0042487Venous Thrombosis5GAD,LHGDN
umls:C0005586Bipolar Disorder4BeFree
umls:C0023903Liver neoplasms4BeFree
umls:C0149871Deep Vein Thrombosis4BeFree
umls:C0151468Thyroid Gland Follicular Adenoma4BeFree
umls:C2239176Liver carcinoma4BeFree
umls:C0002793Anaplasia3BeFree
umls:C0003873Rheumatoid Arthritis3BeFree
umls:C0004779Basal Cell Nevus Syndrome3BeFree
umls:C0023418leukemia3BeFree
umls:C0023895Liver diseases3BeFree
umls:C0025202melanoma3BeFree
umls:C0027666Neoplasms, Radiation-Induced3BeFree
umls:C0040128Thyroid Diseases3BeFree
umls:C0040147Thyroiditis3BeFree
umls:C0205696Anaplastic carcinoma3BeFree
umls:C0206664Teratocarcinoma3BeFree
umls:C0235290Taste bitter3BeFree
umls:C0238462Medullary carcinoma of thyroid3BeFree
umls:C0242225Color blindness3BeFree
umls:C0340708Deep vein thrombosis of lower limb3BeFree
umls:C0850803Anaphylaxis (non medication)3BeFree
umls:C1337013Differentiated Thyroid Gland Carcinoma3BeFree
umls:C1839839MAJOR AFFECTIVE DISORDER 23BeFree
umls:C0001973Alcoholic Intoxication, Chronic2BeFree
umls:C0004364Autoimmune Diseases2BeFree
umls:C0006142Malignant neoplasm of breast2BeFree
umls:C0008626Congenital chromosomal disease2BeFree
umls:C0010674Cystic Fibrosis2BeFree
umls:C0015523Factor XI Deficiency2GAD,LHGDN
umls:C0018023Nodular Goiter2BeFree
umls:C0023492Leukemia, T-Cell2BeFree
umls:C0027726Nephrotic Syndrome2BeFree
umls:C0029408Degenerative polyarthritis2BeFree
umls:C0032580Adenomatous Polyposis Coli2BeFree
umls:C0033626Protein Deficiency2BeFree
umls:C0079474Hallopeau-Siemens Disease2BeFree
umls:C0086692Benign Neoplasm2BeFree
umls:C0178874Tumor Progression2BeFree
umls:C0272322Severe hereditary factor VIII deficiency disease2BeFree
umls:C0311361Adenomatous goiter2BeFree
umls:C0342208Multinodular goiter2BeFree
umls:C0476073Papillary neoplasm2BeFree
umls:C0600433Activated Protein C Resistance2BeFree
umls:C0678222Breast Carcinoma2BeFree
umls:C1136249Mental Retardation, X-Linked2BeFree
umls:C1266050Poorly Differentiated Thyroid Carcinoma2BeFree
umls:C1527249Colorectal Cancer2BeFree
umls:C1861171THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder)2BeFree
umls:C0001175Acquired Immunodeficiency Syndrome1BeFree
umls:C0002736Amyotrophic Lateral Sclerosis1BeFree
umls:C0003499Supravalvular aortic stenosis1BeFree
umls:C0004943Behcet Syndrome1BeFree
umls:C0007570Celiac Disease1BeFree
umls:C0008354Cholera1BeFree
umls:C0009402Colorectal Carcinoma1BeFree
umls:C0010346Crohn Disease1BeFree
umls:C0013336Dwarfism1BeFree
umls:C0014072Experimental Autoimmune Encephalomyelitis1BeFree
umls:C0014743Erythema Nodosum1BeFree
umls:C0015503Factor VII Deficiency1BeFree
umls:C0019080Hemorrhage1GAD
umls:C0019158Hepatitis1BeFree
umls:C0019159Hepatitis A1BeFree
umls:C0021051Immunologic Deficiency Syndromes1BeFree
umls:C0021655Insulin Resistance1GAD
umls:C0022408Arthropathy1BeFree
umls:C0023890Liver Cirrhosis1GAD
umls:C0025149Medulloblastoma1BeFree
umls:C0025269Multiple Endocrine Neoplasia Type 2b1BeFree
umls:C0025362Mental Retardation1BeFree
umls:C0026705Mucopolysaccharidosis II1BeFree
umls:C0026769Multiple Sclerosis1BeFree
umls:C0026850Muscular Dystrophy1BeFree
umls:C0027051Myocardial Infarction1BeFree
umls:C0028259Nodule1BeFree
umls:C0031511Pheochromocytoma1BeFree
umls:C0033860Psoriasis1BeFree
umls:C0034065Pulmonary Embolism1BeFree
umls:C0035335Retinoblastoma1BeFree
umls:C0037286Skin Neoplasms1BeFree
umls:C0039103Synovitis1BeFree
umls:C0040038Thromboembolism1BeFree
umls:C0040053Thrombosis1CTD_human
umls:C0042769Virus Diseases1BeFree
umls:C0042974von Willebrand Disease1BeFree
umls:C0085110Severe Combined Immunodeficiency1BeFree
umls:C0085669Acute leukemia1BeFree
umls:C0151779Cutaneous Melanoma1BeFree
umls:C0151942Arterial thrombosis1BeFree
umls:C0151950Deep thrombophlebitis1BeFree
umls:C0206693Medullary carcinoma1BeFree
umls:C0206716Ganglioglioma1BeFree
umls:C0235782Gallbladder Carcinoma1BeFree
umls:C0242379Malignant neoplasm of lung1BeFree
umls:C0242666Protein S Deficiency1BeFree
umls:C0263361Psoriasis vulgaris1BeFree
umls:C0265325Turcot syndrome (disorder)1BeFree
umls:C0272317Hereditary factor II deficiency disease1BeFree
umls:C0272375Antithrombin III Deficiency1BeFree
umls:C0276275Disease due to Parvoviridae1BeFree
umls:C0280100Solid tumour1BeFree
umls:C0349639Juvenile Myelomonocytic Leukemia1BeFree
umls:C0375019Human T-cell lymphotrophic virus, type I [HTLV-I]1BeFree
umls:C0376288Amaurosis1BeFree
umls:C0398625Protein C Deficiency1BeFree
umls:C0432291Mandibuloacral dysostosis1BeFree
umls:C0474808Follicular neoplasm1BeFree
umls:C0497550Benign neurologic neoplasms1BeFree
umls:C0524851Neurodegenerative Disorders1BeFree
umls:C0584960Factor V Leiden mutation1BeFree
umls:C0587248Costello syndrome (disorder)1BeFree
umls:C0600452Hepatopulmonary Syndrome1GAD
umls:C0684249Carcinoma of lung1BeFree
umls:C0699885Carcinoma of bladder1BeFree
umls:C0744310gastritis h pylori1BeFree
umls:C0795801trisomy 21BeFree
umls:C0850666Helicobacter pylori infection1BeFree
umls:C0852077Blood Coagulation Disorders, Inherited1BeFree
umls:C0920420cancer recurrence1BeFree
umls:C0948216Ovarian adenocarcinoma1BeFree
umls:C1096488Hereditary factor IX deficiency disease without inhibitor1BeFree
umls:C1292769Precursor B-cell lymphoblastic leukemia1BeFree
umls:C1318500Non-toxic nodular goiter1BeFree
umls:C1561955Fibrinogen Adverse Event1GAD
umls:C2608079WARFARIN SENSITIVITY (disorder)1GAD
umls:C2749016Thrombophilia, X-Linked, Due To Factor Ix Defect1CLINVAR,CTD_human,UNIPROT
umls:C3811653Experimental Organism Basal Cell Carcinoma1BeFree
umls:C0750384Coumarin Resistance0CTD_human